Health and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells pediatric nutrition, baby care, adult nutrition...
Health and Happiness (H&H) International Holdings (1112.HK) staged a low-open rally, closing up 6.59% at HK$11.32, fueled by strong Q4 earnings and bullish institutional sentiment. The stock opened at HK$10.68 and rebounded sharply, hitting an intraday high of HK$11.47 with total turnover of approximately HK$21.15 million. Q4 operating revenue rose 20.55% YoY to HK$4.078 billion, net profit surged 136.38% YoY to HK$69.57 million, and EPS jumped 136.32% YoY to HK$0.1084, underscoring a significant profitability turnaround. CLSA and China Merchants Securities recently reiterated Buy ratings. However, the stock remains down 13.85% year-to-date and 32.62% off its 52-week high of HK$16.80, now trading above its 20-day MA (HK$10.80) but below the 60-day MA (HK$12.36), leaving the divergence between short-term momentum and medium-term trend as a cautionary note.
健合国际今日低开高走,开盘短暂下探 10.26 港元的日内低点后震荡上行,下午盘一度触及 10.70 港元高位,最终收报 10.60 港元,较前收 10.18 港元涨 4.1%。推动股价的主要利好来自一季度财报改善,营收 40.78 亿港元同比增长 20.55%,净利润 6957 万港元同比猛增 136.38%,EPS 达 0.1084 港元,较上年同期增逾 1.3 倍。此外,CLSA 与招商证券近期重申买入评级,且公司于世界微生物日推广婴幼儿益生菌新品,强化了市场情绪。不过,当前股价距 52 周高点 16.8 港元仍下滑 36.9%,且低于 20 日均线 (10.805 港元) 和 60 日均线 (12.377 港元),估值修复尚需更多业绩确认。
The End of the Mega-Platform: How Niche Ecosystems Are Quietly Taking Over the Hong Kong Market in 2026
Hong Kong Cross-Sector Moves: Key Catalysts for 10 Equities From Biotech to Industrials
CLSA Remains a Buy on Health and Happiness (H&H) International Holdings (BTSDF)
H&H unit Biostime Healthy Australia appeals ATO tax decision in Federal Court
CICC Raises H&H INTL HLDG TP to HKD18.8; 1H Operating Data Beat Expectations
CICC Sticks to Its Buy Rating for Health and Happiness (H&H) International Holdings (BTSDF)